| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00419536 Details | 2010-04-08 Interventional | 1 | - | Panobinostat Prostatic Neopl… Hormone Refract… | - - | |||
| NCT00171847 Details | 2010-03-31 Interventional | 4 | 93 | Letrozole Trastuzumab Breast Neoplasm… Metastatic Brea… | - - | |||
| NCT00201344 Details | 2010-03-26 Interventional | 3 | - | Leucovorin Carcinoma Nasopharyngeal … | - - | |||
| NCT00638326 Details | 2010-03-23 Interventional | 3 | - | Clopidogrel Angina Pectoris Angina, Stable Ad Hoc Percutan… Stable Angina P… | Greater differences between randomized patients than previously anticipated - | |||
| NCT00333307 Details | 2010-03-16 Interventional | 1 | - | Methocarbamol Eclampsia Pre-Eclampsia | - - | |||
| NCT00102115 Details | 2010-03-12 Interventional | 1 | - | Talaporfin Choroidal Neova… Macular Degener… Neovascularizat… | - - | |||
| NCT00359450 2005-005099-33 Details | 2010-03-02 Interventional | 2 | - | Taxane Carcinoma, Non-… Lung Neoplasms Non-small Cell … | - - | |||
| NCT00332748 Details | 2010-03-02 Interventional | 1 | - | Taxane Cancer | - - | |||
| NCT00326131 Details | 2010-03-02 Interventional | 1 | - | Taxane Cancer | - - | |||
| NCT00918450 Details | 2010-02-26 Interventional | 2 | - | Navitoclax Leukemia Leukemia, Lymph… Leukemia, Lymph… B-cell Chronic … | Sponsor has decided to not proceed with this study. - | |||
| NCT00909558 Details | 2010-02-24 Interventional | 1 | - | Immunomodulatin… Carcinoma, Hepa… Colonic Neoplas… Liver Neoplasms Pancreatic Neop… Prostatic Neopl… Breast Cancer Colon Cancer Glioma Hepatocellular … Pancreatic Canc… Prostate Cancer Squamous Cell L… | - - | |||
| NCT00787111 Details | 2010-02-23 Interventional | 3 | - | Fluoxetine Autistic Disord… | - - | |||
| NCT00904605 Details | 2010-02-15 Interventional | 4 | - | Celecoxib Osteoarthritis Osteoarthritis,… Osteoarthritis … | Safety concerns with the COX-2 specific inhibitor class of drug. - | |||
| NCT00904397 Details | 2010-02-15 Interventional | 4 | 98 | Celecoxib Lidocaine Back Pain Low Back Pain Chronic Low Bac… | Rofecoxib was withdrawn from the market due to safety concerns. - | |||
| NCT00696631 NCT00543699 Details | 2010-02-15 Interventional | 3 | [1 Refs] | 653 | Dronedarone Heart Failure Congestive Hear… | Terminated as the active treatment was associated with an increased hazard - | ||
| NCT00537602 Details | 2010-02-12 Interventional | 2 | 6 | Miglustat Cystic Fibrosis Fibrosis | Methodology applied did not meet all criteria required per guidelines - | |||
| NCT00532454 Details | 2010-02-10 Interventional | 2 | 21 | Tamoxifen Breast Neoplasm… Neoplasm Metast… Breast Cancer Metastatic Dise… | planned to design a prospective study - | |||
| NCT00642421 Details | 2010-02-09 Interventional | 3 | - | Octreotide Acromegaly | Commercial reasons - | |||
| NCT00958269 Details | 2010-02-03 Interventional | 3 | - | Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… Renal Insuffici… Renal Impairmen… Type 2 Diabetes… | Technical/operational issues - | |||
| NCT00080509 Details | 2010-02-03 Interventional | 2 | - | Desoxyepothilon… Lung Neoplasms Lung Cancer | - - |